Purpose To analyze the oncological outcomes and patterns of recurrence of patients with
locoregionally advanced oropharyngeal squamous cell carcinoma (OPSCC) who underwent …

Background This study presents oncologic outcomes after transoral robotic surgery
(TORS)±adjuvant therapy for oropharyngeal squamous cell carcinoma (SCC). Methods …

Background A prospective clinical trial of combination neoadjuvant chemotherapy, transoral
robotic surgery (TORS), and customized adjuvant therapy for patients with locally advanced …

Objectives To analyze the oncological and functional outcomes of patients with stage III-IV
laryngo-hypopharyngeal cancer who underwent neoadjuvant chemotherapy (NAC) with …

Objectives To analyse the oncological outcomes following primary Transoral Robotic
Surgery (TORS) for oropharyngeal squamous cell carcinoma (OPSCC). Design …

Background We aimed to identify the optimal indications of neoadjuvant chemotherapy
(NACT) and transoral robotic surgery (TORS) in patients with locoregionally advanced (T3‐4 …

Purpose Optimal treatment strategies for the management of oropharyngeal squamous cell
carcinoma (OPSCC) remain unclear. The objective of this study is to examine the role of …

Objectives/Hypothesis To assess adjuvant therapy in patients undergoing surgical
management of oropharyngeal squamous cell carcinoma (OPSCCA) with transoral robotic …

Objective TORS-based therapy including chemotherapy or RTx was administered to patients
with stage III-IV OPSCC. We analyzed the oncological and functional outcomes of stage III-IV …

Abstract Objectives Trans Oral Robotic Surgery (TORS) is a fascinating new technique that
has proved to be a safe and feasible treatment of oropharyngeal squamous cell carcinoma …